Hanhui Pharma leverages on the National Enterprise Technology Center and post-doctoral research workstation of its parent company, Hisun Pharmaceutical, specializes in developing small-molecule drugs, builds and optimizes the pharmaceutical R&D platform with an open cooperative R&D mode, conducts CMC study with Zhejiang Pharmaceutical College and China Pharmaceutical University, and conducts CMC and BE studies as well as clinical research cooperation with pharmaceutical/clinical well-known CRO companies. In addition, the company operates a R&D team for diabetes drugs, specializing in product development and technical innovation, and is committed to providing high-quality products and technical services to our customers.